IRIS
RIGOTTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.965
AS - Asia 2.573
EU - Europa 2.148
SA - Sud America 379
Continente sconosciuto - Info sul continente non disponibili 179
AF - Africa 56
AN - Antartide 2
OC - Oceania 1
Totale 8.303
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.868
RU - Federazione Russa 1.357
SG - Singapore 1.017
CN - Cina 961
BR - Brasile 317
RO - Romania 269
HK - Hong Kong 260
VN - Vietnam 158
IT - Italia 142
FR - Francia 122
DE - Germania 70
CA - Canada 47
GB - Regno Unito 47
IN - India 39
BD - Bangladesh 29
ZA - Sudafrica 26
NL - Olanda 24
AR - Argentina 23
MX - Messico 23
SE - Svezia 21
FI - Finlandia 20
PL - Polonia 20
AT - Austria 16
IQ - Iraq 14
ES - Italia 13
TR - Turchia 13
EC - Ecuador 11
DZ - Algeria 10
ID - Indonesia 10
JP - Giappone 10
MY - Malesia 10
CO - Colombia 9
CR - Costa Rica 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
LT - Lituania 7
PK - Pakistan 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
MA - Marocco 5
OM - Oman 5
PH - Filippine 5
TN - Tunisia 5
KE - Kenya 4
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
LB - Libano 3
NI - Nicaragua 3
PE - Perù 3
SV - El Salvador 3
UA - Ucraina 3
AQ - Antartide 2
AZ - Azerbaigian 2
BO - Bolivia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BE - Belgio 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MK - Macedonia 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
Totale 8.125
Salva come PNG Salva come JPEG
Città #
Dallas 1.163
Singapore 518
San Jose 485
Moscow 329
Hong Kong 258
Ashburn 236
Shanghai 219
Council Bluffs 121
Hefei 115
Lauterbourg 99
Beijing 82
Phoenix 71
Ho Chi Minh City 53
New York 48
Los Angeles 44
Hanoi 42
Guangzhou 35
Boardman 30
Santa Clara 29
Milan 28
Chennai 27
São Paulo 24
Brooklyn 23
Johannesburg 23
Chicago 21
Shenzhen 19
Nuremberg 18
Munich 17
Amsterdam 16
London 16
Orem 16
Rome 16
Warsaw 16
Montreal 14
Omaha 13
Assago 12
Atlanta 12
Helsinki 12
Rio de Janeiro 12
Boston 11
Mexico City 11
Stockholm 11
Frankfurt am Main 10
Houston 10
Poplar 10
Seattle 10
Tokyo 10
Toronto 10
Belo Horizonte 9
Washington 9
Brasília 8
Da Nang 8
Haiphong 8
Jiaxing 8
Manchester 8
Paris 8
San Francisco 8
Algiers 7
Charlotte 7
Denver 7
Kuala Lumpur 7
Baghdad 6
Cesano Boscone 6
Guarulhos 6
Porto Alegre 6
Quito 6
Thái Nguyên 6
Wuxi 6
Ankara 5
Brescia 5
Campinas 5
Curitiba 5
Fuzhou 5
Hangzhou 5
Jacksonville 5
Lawrence 5
Philadelphia 5
Princeton 5
Queens 5
Reston 5
San José 5
Tashkent 5
Vienna 5
Birmingham 4
Buenos Aires 4
Buffalo 4
Dhaka 4
Dubai 4
Fortaleza 4
Guayaquil 4
Lappeenranta 4
Miami 4
Muscat 4
Nairobi 4
Turku 4
Uberlândia 4
West Jordan 4
Bologna 3
Bến Tre 3
Carney 3
Totale 4.709
Salva come PNG Salva come JPEG
Nome #
105.3: Analysis of Autoimmune Re-activation After COVID-19 mRNA Vaccination in Pancreas Transplant Recipients 1.388
ABCB1 Genotypes Predict Cyclosporine-Related Adverse Events and Kidney Allograft Outcome 105
Acute rejection features in dual kidney transplant recipients fromelderly donors: comparison of calcineurin inhibitor-based and calcineurininhibitor-free immunosuppressive protocols 101
First World Consensus Conference on Pancreas Transplantation: Part II - recommendations 101
C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients:single-center incidence and outcome 100
COVID-19 and kidney transplantation: an Italian Survey and Consensus 98
Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients 94
First world consensus conference on pancreas transplantation: Part I—Methods and results of literature search 94
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 92
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment 92
Kidney Donation after circulatory death: The Veneto Region experience in Italy 92
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 91
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 89
The era of the new directly acting antivirals: Has the time come for kidney transplant only in compensated cirrhosis? 89
ADVANTAGES OF PSI plus LOW-DOSE CNI VS PSI ALONE IN DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS 87
Alefacept Combined With Tacrolimus, Mycophenolate Mofetil and Steroids in De Novo Kidney Transplantation: A Randomized Controlled Trial 86
Perioperative strategies: Taking care of the elderly patient with severe advanced comorbidities needing acute surgery 85
A RARE CAUSE OF ULCERATIVE LESION OF THE PALATE AND FEVER IN A RENAL-TRANSPLANT RECIPIENT 83
A single-center experience with 200 dual kidney transplantations 82
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids? 82
Correction to: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression (Oncogenesis, (2018), 7, 6, (46), 10.1038/s41389-018-0055-5) 81
Kidney exchange strategies: new aspects and applications with a focus on deceased donor-initiated chains 81
Assessment of Adherence To Medical Regimen After Solid Organ Transplantation: the Experience of Padova University Hospital 80
Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review 77
[Living donor kidney transplant: the surgical procedure] 77
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: A randomized phase III study 76
Coronary Microvascular Dysfunction Predicts Long-Term Outcome in Simultaneous Pancreas-Kidney Transplantation 76
Autosomal Dominant Polycystic Kidney Disease 76
DNA Methylation - and Telomere - Based Biological Age Estimation as Markers of Biological Aging in Donors Kidneys 73
Glomerulitis and endothelial cell enlargement in C4d(+) and C4d(-) acute rejections of renal transplant patients 70
Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors 69
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial 69
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 68
Telemedicine monitoring in the follow-up of kidney transplant recipients: consensus indications from an Italian panel of surgeons and nephrologists after the COVID-19 experience 68
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies 67
Outcome and quality of life of patients with augmented bladder or urinary diversion after kidney transplantation 65
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation 65
Pulse pressure variation guided fluid therapy during kidney transplantation: a randomized controlled trial 64
Lower Urinary Tract Symptoms in Kidney Transplant Recipients and Timing of Treatment With TURP: Impact on Renal Graft Survival and Function 63
Persistent Secondary Hyperparathyroidism and Vertebral Fractures in Kidney Transplantation: Role of Calcium-Sensing Receptor Polymorphisms and Vitamin D Deficiency 63
Surgical complications in simultaneous pancreas and kidney transplantation (SPK) with enteric exocrine drainage and systemic venous drainage 62
Headache in kidney transplantation 61
LONG TERM RESULTS OF A LARGE EXPERIENCE OF DOUBLE KIDNEY TRANSPLANTATION (DKT) PERFORMED AT A SINGLE CENTER 61
Kidney Autotransplantation for Renal Artery Aneurysm: Case Series and a Systematic Review 60
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma 60
Erratum: Optimizing utilization of kidneys from deceased donors over 60 years: Five-year outcomes after implementation of a combined clinical and histological allocation algorithm (Transplant International (2013) 26 (833)) 59
Transplantation: can a single criterion determine the use of ECD kidneys? 59
Surgical overview on kidney and pancreas transplantation 59
Laparoscopic and robot-assisted nephrectomy 58
Ex Vivo open reconstruction of hilar renal artery aneurysms: a silngle-center experience 57
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial 57
Everolimus Associated With Low-Dose Calcineurin Inhibitors, an Option in Kidney Transplant Recipients of Very Old Donors 57
SEMEIOTICA CHIRURGICA 57
PROLIFERATION SIGNAL INHIBITORS (PSI) CAN BE SAFELY USED AB INITIO AFTER DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS (ED) 56
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 56
Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy 56
Deceased donor-initiated Chains: first report of a successful deliberate case and its ethical implications 56
Non-compliance after solid organ transplantation: the experience of Padua University Hospital 56
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study 55
Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label Trial 55
Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantation 55
DUAL KIDNEY TRANSPLANTATION FROM ELDERLY DONORS: LONG TERM OUTCOME AND HISTOLOGICAL FEATURES 55
How Long Does It Take to Acquire Mastery of Performance in Laparoscopic Living Donor Nephrectomy? A Center-Based and Surgeon-Based Operative Time CUSUM Analysis 55
The debate on preemptive transplantation: queries and limits 54
Xenotransplantation of solid organs in the pig-to-primate model 54
Organ Donors with Small Renal Cancer: Report of 3 Cases 54
In vitro and in vivoimmunomodulatory effects of cobalt protoporphyrin administered in combinationwith immunosuppressive drugs 53
Everolimus with very low-exposure cyclosporine A in de Novo kidney transplantation: A multicenter, randomized, controlled trial 53
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 53
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients 53
Dual kidney transplantation after liver transplantation: a good option to rescue a patient from dialysis 52
Glomerulitis in acute rejection of renal transplant patients 52
Physical Activity in Solid Organ Transplant Recipients: Organizational Aspects and Preliminary Results of the Italian Project 52
Refinement of a primate xenotransplantation model: application of a subcutaneously implanted port as a means of gastric nutrition 52
Glomerular C4d Immunoreactivity in Acute Rejection Biopsies of Renal Transplant Patients 52
Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009 52
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 51
Sotrastaurin, a Novel Small Molecule Inhibiting Protein Kinase C: First Clinical Results in Renal-Transplant Recipients 51
EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION: PRELIMINARY RESULTS OF A MULTICENTER STUDY 51
Outcome of Renal Transplantation from Very Old Donors 51
MAXIMIZING THE SUCCESS OF TRANSPLANTATION WITH KIDNEYS FROM OLDER DONORS: LONG-TERM RESULTS OF A MULTICENTER, PROSPECTIVE STUDY 51
Therapeutic apheresis in kidney AB0 incompatible transplantation 50
EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC T-CELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS 50
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study 50
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 49
Early activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies 49
Evaluation of coronary microvascular function by coronary flow reserve (cfr) measurement in simultaneous pancreas and kidney transplantation (spk) allograft recipients 48
Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials 48
Sirolimus-Based Therapy For Kidney Transplantation From Expanded Criteria Donors 48
Evaluation of Endothelial Cell Enlargement in Glomerulitis 48
Transplantation: Optimizing outcomes in elderly kidney transplant recipients 47
Refinement of a primate model: Long-term enteral administration of drugs or nutritional supplementary by a subcutaneously implanted port 46
CYCLOSPORIN A AND TACROLIMUS, COMBINED WITH MYCOPHENOLIC ACID, ARE EQUALLY EFFECTIVE IN PREVENTING THE ONSET OF DE NOVO ANTI-HLA ANTIBODIES 46
MicroRNAs: nuovi biomarcatori predittivi di sviluppo di insufficienza renale cronica e ipertensione arteriosa nei pazienti sottoposti a nefrectomia radicale per carcinoma renale. 46
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients 46
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 45
Excellent Performance of Kidneys from Octogenarian Donors Transplanted as Dual Kidney Transplantation 45
Nonadherent Behaviors After Solid Organ Transplantation 45
Immunosoppressive Therapy and Risk of Post-Transplant Malignancies after Kidney Transplantation: Italian Multicentric Study 44
Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-Year observational results 44
Totale 7.716
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 1 1 0 0 0 0 1 0 0 0
2022/202328 13 4 2 0 0 3 0 0 2 1 1 2
2023/2024329 1 1 0 0 0 0 0 145 34 8 33 107
2024/20251.990 187 18 21 98 214 151 542 150 234 103 120 152
2025/20265.372 383 549 957 536 303 110 630 272 1.218 212 84 118
2026/2027577 144 319 114 0 0 0 0 0 0 0 0 0
Totale 8.303